The essentiality of α-2-macroglobulin in human salivary innate immunity against new H1N1 swine origin influenza A virus

Proteomics

Volumn 10, Issue 12, 2010, Pages 2396-2401

  Chen, Chao Hsuan ^a,b,c   Zhang, Xing Quan ^d   Lo, Chih Wei ^a,b,e   Liu, Pei Feng ^a,b   Liu, Yu Tsueng ^d,f   Gallo, Richard L ^a,b   Hsieh, Ming Fa ^c   Schooley, Robert T ^d   Huang, Chun Ming ^a,b,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^f UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

2,6 sialylated glycoproteins; 2 macroglobulin; H1N1 swine origin influenza A virus; Microbiology; Salivary innate immunity

Indexed keywords

ALPHA 2 MACROGLOBULIN; PROTEINASE;

ARTICLE; HUMAN; INFLUENZA VIRUS A H1N1; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; SALIVA; SIALYLATION; VIRUS HEMAGGLUTINATION; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ALPHA-MACROGLOBULINS; GLYCOPROTEINS; HUMANS; IMMUNITY, INNATE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MODELS, THEORETICAL; SALIVA;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE; SUIDAE;

EID: 77953822269     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200900775     Document Type: Article

References (31)

1. Lu, Q., Zhang, X. Q., Pond, S. L., Reed, S. et al., Detection in 2009 of the swine origin influenza A (H1N1) virus by a subtyping microarray. J. Clin. Microbiol. 2009, 47, 3060-3061.
2. Rogers, G. N., Paulson, J. C., Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 1983, 127, 361-373.
3. Qi, L., Kash, J. C., Dugan, V. G., Wang, R. et al., Role of sialic acid binding specificity of the 1918 influenza virus hemagglutinin protein in virulence and pathogenesis for mice. J. Virol. 2009, 83, 3754-3761.
4. Peschel, A., Sahl, H. G., The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 2006, 4, 529-536.
5. Roella, G., Investigations of some effects of human saliva on Influenza Virus. 2. Kinetics of haemagglutination inhibition. A comparison of unspecific inhibition by saliva and inhibition by immune serum. Acta Pathol. Microbiol. Scand. 1965, 64, 224-228.
6. Roella, G., Investigations of some effects of human saliva on Influenza Virus. 1. Haemagglutination inhibition and neutralization. Acta Pathol. Microbiol. Scand. 1965, 63, 291-298.
7. Seltsam, J. H., Lanni, F., Beard, J. W., Inhibitory effect of human saliva on hemagglutination by influenza virus A (PR8 strain) and the swine influenza virus. J. Immunol. 1949, 63, 261-271.
8. Francis, T., Jr., Minuse, E., Influence of saliva upon hemagglutination by influenza virus. Proc. Soc. Exp. Biol. Med. 1948, 69, 291-294.
9. Palese, P., Tobita, K., Ueda, M., Compans, R. W., Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 1974, 61, 397-410.
10. Klenk, H. D., Rott, R., Orlich, M., Blodorn, J., Activation of influenza A viruses by trypsin treatment. Virology 1975, 68, 426-439.
11. Lazarowitz, S. G., Choppin, P. W., Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. Virology 1975, 68, 440-454.
12. Klenk, H. D., Garten, W., Host cell proteases controlling virus pathogenicity. Trends Microbiol. 1994, 2, 39-43. (Pubitemid 24051419)
13. Steinhauer, D. A., Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 1999, 258, 1-20. (Pubitemid 29391776)
14. Ito, T., Suzuki, Y., Mitnaul, L., Vines, A. et al., Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species. Virology 1997, 227, 493-499. (Pubitemid 27241043)
15. Childs, R. A., Palma, A. S., Wharton, S., Matrosovich, T. et al., Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat. Biotechnol. 2009, 27, 797-799.
16. White, M. R., Helmerhorst, E. J., Ligtenberg, A., Karpel, M. et al., Multiple components contribute to ability of saliva to inhibit influenza viruses. Oral. Microbiol. Immunol. 2009, 24, 18-24.
17. Hartshorn, K. L., White, M. R., Mogues, T., Ligtenberg, T. et al., Lung and salivary scavenger receptor glycoprotein-340 contribute to the host defense against influenza A viruses. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 285, L1066-L1076.
18. Sun, X., Salih, E., Oppenheim, F. G., Helmerhorst, E. J., Activity-based mass spectrometric characterization of proteases and inhibitors in human saliva. Proteomics Clin. Appl. 2009, 3, 810-820.
19. Pederson, E. D., Stanke, S. R., Whitener, S. J., Sebastiani, P. T. et al., Salivary levels of alpha 2-macroglobulin, alpha 1-antitrypsin, C-reactive protein, cathepsin G and elastase in humans with or without destructive periodontal disease. Arch. Oral. Biol. 1995, 40, 1151-1155.
20. Steiner, I., Sobieska, M., Pucher, B., Grzegorowski, M., Samborski, W., [Examination of acute phase proteins concentrations in children with allergic rhinitis]. Ann. Acad. Med. Stetin. 2006, 52, 33-37; discussion 37.
21. Out, T. A., Jansen, H.M., van Steenwijk, R. P., de Nooijer, M. J. et al., ELISA of ceruloplasmin and alpha-2-macroglobulin in paired bronchoalveolar lavage fluid and serum samples. Clin. Chim. Acta 1987, 165, 277-288.
22. Pritchett, T. J., Paulson, J. C., Basis for the potent inhibition of influenza virus infection by equine and guinea pig alpha 2-macroglobulin. J. Biol. Chem. 1989, 264, 9850-9858.
23. Hanaoka, K., Pritchett, T. J., Takasaki, S., Kochibe, N. et al., 4-O-acetyl-N-acetylneuraminic acid in the N-linked carbohydrate structures of equine and guinea pig alpha 2-macroglobulins, potent inhibitors of influenza virus infection. J. Biol. Chem. 1989, 264, 9842-9849. (Pubitemid 19159248)
24. Rogers, G. N., Pritchett, T. J., Lane, J. L., Paulson, J. C., Differential sensitivity of human, avian, and equine influenza A viruses to a glycoprotein inhibitor of infection: selection of receptor specific variants. Virology 1983, 131, 394-408.
25. Borth, W., Alpha 2-macroglobulin, a multifunctional binding protein with targeting characteristics. FASEB J. 1992, 6, 3345-3353. (Pubitemid 23007099)
26. Kendal, A. P., Apostolov, K., Belyavin, G., The effect of protease treatment on the morphology of influenza A, B and C viruses. J. Gen. Virol. 1969, 5, 141-143.
27. Galliano, M. F., Toulza, E., Gallinaro, H., Jonca, N. et al., A novel protease inhibitor of the alpha2-macroglobulin family expressed in the human epidermis. J. Biol. Chem. 2006, 281, 5780-5789. (Pubitemid 43847677)
28. Dwomiczak, S., Ziora, D., Konofalski, L., Szalaty, M. et al., Analysis of alpha-1-antitrypsin phenotypes and genotypes in patients with early-onset pulmonary emphysema. Pneumonol. Alergol. Pol. 2005, 73, 12-17.
29. Churg, A., Wang, R. D., Xie, C., Wright, J. L., Alpha- 1-Antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse. Am. J. Respir. Crit. Care Med. 2003, 168, 199-207. (Pubitemid 36920974)
30. Russi, E. W., Alpha-1 antitrypsin: now available, but do we need it? Swiss Med. Wkly. 2008, 138, 191-196.
31. Brass, A. L., Huang, I. C., Benita, Y., John, S. P. et al., The IFITM proteins mediate cellular resistance to Influenza A H1N1 virus, West Nile virus, and Dengue virus. Cell 2009, 139, 1243-1254.